Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Butz

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Oncogene|February 8, 2006
Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoproteinM Vogt, K Butz, S Dymalla, et al.
Oncogene|May 18, 1999
Induction of the p53-target gene GADD45 in HPV-positive cancer cellsK Butz, N Whitaker, C Denk, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 4, 2000
Differential cell cycle response of nontumorigenic and tumorigenic human papillomavirus-positive keratinocytes towards transforming growth factor-beta1J Hasskarl, K Butz, N Whitaker, et al.
Oncogene|March 2, 1995
Functional p53 protein in human papillomavirus-positive cancer cellsK Butz, L Shahabeddin, C Geisen, et al.
Journal of Virology|September 1, 1995
Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promotersM Hörer, S Weger, K Butz, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 4, 2001
Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcriptionM Beger, K Butz, C Denk, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 22, 2001
Peptide aptamers: new tools to study protein interactionsF Hoppe-Seyler, I Crnkovic-Mertens, C Denk, et al.
Oncogene|October 20, 2001
Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activityK Butz, C Denk, B Fitscher, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
A validated strategy to select patients for a nerve-sparing radical prostatectomyM Graefen, U Pichlmeier, P G Hammerer, et al.
Cellular and Molecular Life Sciences : CMLS|April 18, 2007
Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosisI Crnković-Mertens, N Wagener, J Semzow, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Oncogene|February 8, 2006
Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoproteinM Vogt, K Butz, S Dymalla, et al.
Oncogene|May 18, 1999
Induction of the p53-target gene GADD45 in HPV-positive cancer cellsK Butz, N Whitaker, C Denk, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 4, 2000
Differential cell cycle response of nontumorigenic and tumorigenic human papillomavirus-positive keratinocytes towards transforming growth factor-beta1J Hasskarl, K Butz, N Whitaker, et al.
Oncogene|March 2, 1995
Functional p53 protein in human papillomavirus-positive cancer cellsK Butz, L Shahabeddin, C Geisen, et al.
Journal of Virology|September 1, 1995
Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promotersM Hörer, S Weger, K Butz, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 4, 2001
Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcriptionM Beger, K Butz, C Denk, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 22, 2001
Peptide aptamers: new tools to study protein interactionsF Hoppe-Seyler, I Crnkovic-Mertens, C Denk, et al.
Oncogene|October 20, 2001
Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activityK Butz, C Denk, B Fitscher, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
A validated strategy to select patients for a nerve-sparing radical prostatectomyM Graefen, U Pichlmeier, P G Hammerer, et al.
Cellular and Molecular Life Sciences : CMLS|April 18, 2007
Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosisI Crnković-Mertens, N Wagener, J Semzow, et al.
Pageof 4